Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars—A Systematic Review
Diagnostics · 13.06.2024 · 14 (12) · 1246
DOI: 10.3390/diagnostics14121246 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 13.06.2024. Verfasst von Luis Eduardo Almeida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Sciences Department, School of Dentistry, Marquette University, Milwaukee, WI 53233, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This systematic review investigates the diagnostic, prognostic, and therapeutic implications of immunohistochemical markers in dentigerous cysts (DCs) and odontogenic keratocysts (OKCs) associated with impacted third molars. Materials and Methods: A comprehensive search strategy was employed across major databases including MEDLINE/PubMed, EMBASE, and Web of Science, from the inception of the databases to March 2024. Keywords and Medical Subject Heading (MeSH) terms such as “dentigerous cysts”, “odontogenic keratocysts”, “immunohistochemistry”, “Ki-67”, and “p53” were used. The PRISMA 2020 guidelines were followed to ensure methodological rigor. Inclusion criteria encompassed studies on humans and animals providing definitive diagnoses or specific signs and symptoms related to DCs and OKCs, with results on protein expression derived from immunohistochemistry, immune antibody, proteomics, or protein expression methods.
Results
Of the 159 studies initially identified, 138 met the inclusion criteria. Our analysis highlighted significantly higher expressions of Ki-67 (22.1% ± 4.7 vs. 10.5% ± 3.2, p < 0.001), p53 (15.3% ± 3.6 vs. 5.2% ± 1.9, p < 0.001), and Bcl-2 (18.4% ± 3.2 vs. 8.7% ± 2.4, p < 0.001) in OKCs compared to DCs, indicating a higher proliferative index, increased cellular stress, and enhanced anti-apoptotic mechanisms in OKCs. Additionally, PCNA levels were higher in OKCs (25.6% ± 4.5 vs. 12.3% ± 3.1, p < 0.001). Genetic mutations, particularly in the PTCH1 gene, were frequently observed in OKCs, underscoring their aggressive behavior and potential malignancy.
Conclusions
The findings emphasize the significant role of immunohistochemical markers in distinguishing between DCs and OKCs, with elevated levels of Ki-67, p53, Bcl-2, and PCNA in OKCs suggesting a higher potential for growth and recurrence. Genetic insights, including PTCH1 mutations, further support the need for personalized treatment approaches. These markers enhance diagnostic accuracy and inform targeted therapeutic strategies, potentially transforming patient management in oral and maxillofacial surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surgical Sciences Department, School of Dentistry, Marquette University, Milwaukee, WI 53233, USA.
ORCID-Profile: Luis Eduardo Almeida
Zitieren
APA
Almeida, L. E., Loyd, D., Boettcher, D., Kraft, O., & Zammuto, S. (2024). Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars—A Systematic Review. Diagnostics, 14(12), 1246. https://doi.org/10.3390/diagnostics14121246
Vancouver
Almeida LE, Loyd D, Boettcher D, Kraft O, Zammuto S. Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars—A Systematic Review. Diagnostics. 2024;14(12):1246. doi:10.3390/diagnostics14121246
BibTeX
@article{Almeida2024,
author = {Almeida, Luis Eduardo and Loyd, David and Boettcher, Daniel and Kraft, Olivia and Zammuto, Samuel},
title = {Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars—A Systematic Review},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {12},
pages = {1246},
doi = {10.3390/diagnostics14121246}
}
EUVIMED